All News #Library
Biotech
Alzheon Doses First Subject in ALZ-507 Phase 1 Trial
07 Apr 2026 //
PHARMIWEB
Alzheon Validate Valiltramiprosate Mechanism In Alzheimer Disease
03 Feb 2026 //
BUSINESSWIRE
Alzheon Reports Evidence Supporting Hippocampal Volume Marker
02 Dec 2025 //
BUSINESSWIRE
Alzheon Publishes APOLLOE4 Ph3 Data on Oral ALZ-801 in Early AD
14 Oct 2025 //
BUSINESSWIRE
Alzheon to Present ALZ-801 Data at AAIC Toronto
15 Jul 2025 //
BUSINESSWIRE

Market Place
Sourcing Support